NCT03473743 2025-12-23
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
Janssen Research & Development, LLC
Jonsson Comprehensive Cancer Center
Astellas Pharma Inc